神经病学和神经科学杂志

  • 国际标准期刊号: 2171-6625
  • 期刊 h 指数: 17
  • 期刊引用分数: 4.43
  • 期刊影响因子: 3.38
索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 全球影响因子 (GIF)
  • 中国知网(CNKI)
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 科学期刊影响因子 (SJIF)
  • 欧洲酒吧
  • 谷歌学术
  • 秘密搜索引擎实验室
分享此页面

抽象的

Utilizing Digital Therapeutics (JOGO) to treat Neuromuscular Dyssynergic Defecation

Uma Venkatesa

Digital therapeutics (DTx) , also known as Software as a Medical Device (SaMD) is a newly defined term by the International Medical Device Regulators Forum (IMDRF) for software to be used as a treatment. JOGO is a  DTx that is built based on the science of Electromyography Biofeedback (EMG BF) to facilitate neuromuscular retraining. Combining software and wearable EMG sensors with conventional therapy (CT), JOGO improved the quality of life for a 32 year old patient with slow transit, constipation with type 4 defecation dyssynergia. JOGO’s ease of use through features such as mobile gamification increases patient compliance relative to CT, augmenting clinical outcome. The patient received eight JOGO integrated therapy sessions over the course of three months. Protocol included relaxation exercises (mind and body, including yoga), a high fiber diet, and pelvic floor stretching/relaxation/bulge out exercises, external pelvic muscle stretching (gluteus maximus, hamstrings etc.) and biofeedback therapy. After the sessions, the patient was able to control bowel movements without straining. Initial muscle potential for relaxation was 19 mVs and for contraction was 67 mVs. Post therapy, the patient's muscle potential for relaxation was 9 mVs and for contraction 70 mVs. JOGO integrated therapy helped acquire the goal of improving the patient’s incoordination of pelvic and abdominal muscles. Further studies are in the process to investigate improving this treatment.